Guardant Health Company Top Insiders

GH Stock  USD 45.32  0.92  1.99%   
Guardant Health's insiders are aggressively selling. The analysis of insiders' sentiment of trading Guardant Health stock suggests that almost all insiders are panicking at this time. Guardant Health employs about 2 K people. The company is managed by 15 executives with a total tenure of roughly 16 years, averaging almost 1.0 years of service per executive, having 133.27 employees per reported executive.
Helmy Eltoukhy  CEO
CoCEO CoFounder
AmirAli Talasaz  President
President COO, Director

Insider Sentiment 0

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2025-02-20Musa TariqDisposed 116 @ 48.33View
2025-01-17Musa TariqDisposed 116 @ 37.58View
2024-12-18Musa TariqDisposed 116 @ 34.85View
2024-12-13Musa TariqDisposed 2320 @ 35View
2024-12-02Meghan V JoyceDisposed 100 @ 35.9View
2024-11-13Meghan V JoyceDisposed 2896 @ 29.9View
2024-06-04Meghan V JoyceDisposed 100 @ 27.87View
Monitoring Guardant Health's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.

Guardant Health's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Guardant Health's future performance. Based on our forecasts, it is anticipated that Guardant will maintain a workforce of under 2000 employees by April 2025.
 
Covid

Guardant Health Management Team Effectiveness

The company has Return on Asset (ROA) of (0.1695) % which means that for every 100 dollars spent on asset, it generated a loss of $0.1695. This is way below average. Likewise, it shows a return on total equity (ROE) of (45.8447) %, which implies that it produced no returns to current stockholders. Guardant Health's management efficiency ratios could be used to measure how well Guardant Health manages its routine affairs as well as how well it operates its assets and liabilities. The Guardant Health's current Return On Equity is estimated to increase to 3.28, while Return On Tangible Assets are projected to decrease to (0.31). As of now, Guardant Health's Intangibles To Total Assets are decreasing as compared to previous years. The Guardant Health's current Debt To Assets is estimated to increase to 0.94, while Total Assets are projected to decrease to under 1.4 B.
The current Common Stock Shares Outstanding is estimated to decrease to about 97.6 M. The Guardant Health's current Net Loss is estimated to increase to about (559.7 M)

Guardant Health Workforce Comparison

Guardant Health is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 243,249. Guardant Health maintains roughly 1,999 in number of employees contributing less than 1% to equities under Health Care industry.

Guardant Health Profit Margins

The company has Net Profit Margin (PM) of (0.59) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of (0.63) %, which signifies that for every 100 dollars of sales, it has a net operating loss of $0.63.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.430.6079
Way Down
Slightly volatile

Guardant Health Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Guardant Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Guardant Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Guardant Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2025-03-01
0.8421
64
76
 1,034,309 
 661,695 
2024-12-01
0.8689
53
61
 710,820 
 163,744 
2024-09-01
0.6531
32
49
 78,742 
 74,400 
2024-06-01
0.8644
51
59
 703,754 
 631,630 
2024-03-01
0.7333
33
45
 850,106 
 2,330,359 
2023-12-01
1.0294
35
34
 354,506 
 57,934 
2023-09-01
0.7143
25
35
 283,145 
 30,269 
2023-06-01
1.2105
46
38
 353,496 
 193,749 
2023-03-01
1.1579
22
19
 211,181 
 27,279 
2022-12-01
1.6667
20
12
 324,220 
 5,845 
2022-09-01
1.1667
7
6
 172,502 
 13,218 
2022-06-01
0.619
13
21
 104,894 
 290,243 
2022-03-01
0.5
4
8
 18,110 
 34,158 
2021-12-01
3.2857
23
7
 245,325 
 29,604 
2021-09-01
0.9231
12
13
 175,417 
 80,035 
2021-06-01
0.2045
18
88
 86,086 
 858,232 
2021-03-01
0.0529
9
170
 1,149,490 
 3,775,907 
2020-12-01
0.2895
11
38
 72,484 
 7,341,725 
2020-09-01
0.225
18
80
 351,403 
 1,322,166 
2020-06-01
0.3861
39
101
 3,604,883 
 9,881,143 
2020-03-01
0.3684
14
38
 108,877 
 402,992 
2019-12-01
0.2857
32
112
 344,306 
 1,029,913 
2019-09-01
0.2645
41
155
 699,086 
 6,569,444 
2019-06-01
0.2131
26
122
 316,133 
 1,401,323 
2019-03-01
2.0
2
1
 4,067,980 
 3,000 
2018-12-01
0.717
38
53
 62,484,930 
 89,760,664 

Guardant Health Notable Stakeholders

A Guardant Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Guardant Health often face trade-offs trying to please all of them. Guardant Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Guardant Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Helmy EltoukhyCoCEO CoFounderProfile
AmirAli TalasazPresident COO, DirectorProfile
Jennifer HigginsSenior AffairsProfile
Stephen MurphySenior MarketingProfile
John SaiaChief SecretaryProfile
Christopher FreemanChief OfficerProfile
John JDChief SecretaryProfile
Zarak KhurshidVice RelationsProfile
Terilyn MonroeChief OfficerProfile
Craig MDChief OfficerProfile
Andy AmentVP OperationsProfile
Kumud KaliaChief OfficerProfile
Michael BellChief OfficerProfile
Darya ChudovaVP TechnologyProfile
Darl MorelandSenior QualityProfile

About Guardant Health Management Performance

The success or failure of an entity such as Guardant Health often depends on how effective the management is. Guardant Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Guardant management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Guardant management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.30)(0.31)
Return On Capital Employed(0.35)(0.37)
Return On Assets(0.29)(0.31)
Return On Equity 3.12  3.28 

Guardant Health Workforce Analysis

Traditionally, organizations such as Guardant Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Guardant Health within its industry.

Guardant Health Manpower Efficiency

Return on Guardant Health Manpower

Revenue Per Employee369.7K
Revenue Per Executive49.3M
Net Loss Per Employee218.3K
Net Loss Per Executive29.1M
Working Capital Per Employee415K
Working Capital Per Executive55.3M

Complementary Tools for Guardant Stock analysis

When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments